As expected, high levels of GSK3α were also significantly correlated with unfavorable prognosis in colon cancer patients, whether in 111 tumors of different stages or in tumors of stage II, III, and IV alone (supplemental Fig. S3C). Here, GSK3A is linked to malignant colon neoplasm.